Join
Live feed
·
PRReleasevia Quantisnow
NeOnc Technologies Holdings Inc. logo

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

ByQuantisnow·Wall Street's wire, on your screen.
NTHI· NeOnc Technologies Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NTHI (NeOnc Technologies Holdings Inc.) and more on Quantisnow.